Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  ACB | T.ACB.WS.U

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Comment by Iamsupersson Jan 16, 2019 11:20pm
196 Views
Post# 29243632

RE:RE:I Warned Everyone

RE:RE:I Warned Everyone
DDKhrisna wrote: Do you know how to read a financial statement? ACB has not used it’s BMO credit facility yet. Moreover you will find Tilray and Canopy did the exact same financing a few months ago. I believe Canopy completed the financing in June and got $5B from STZ in August. Suggesting that $ACB has liquidity problems is complete madness. $ACBs senior notes come due in 5 years at which point $ACB can repay with cash or force equity conversion at some point within the 5 years if stock price reaches a certain level. Long story short no dillution in near term if ever. Idiots like you spread lies and false information and people like myself will always be here to check you. 


Very good, hopefully some of the slow learners will read this before stocks open in the morning. 
Bullboard Posts